Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 11 studies | 52% ± 21% | |
| GABAergic neuron | 10 studies | 56% ± 21% | |
| interneuron | 6 studies | 56% ± 21% | |
| neuron | 4 studies | 34% ± 3% | |
| microglial cell | 4 studies | 39% ± 22% | |
| oligodendrocyte precursor cell | 4 studies | 22% ± 3% | |
| retinal ganglion cell | 4 studies | 77% ± 14% | |
| endothelial cell | 3 studies | 53% ± 10% | |
| GABAergic interneuron | 3 studies | 74% ± 8% | |
| GABAergic amacrine cell | 3 studies | 28% ± 12% | |
| OFF-bipolar cell | 3 studies | 40% ± 13% | |
| oligodendrocyte | 3 studies | 39% ± 28% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 13 studies | 38% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 82% | 164.30 | 202 / 245 | 40% | 1.19 | 202 / 502 |
| brain | 94% | 304.02 | 2482 / 2642 | 20% | 0.41 | 138 / 705 |
| spleen | 100% | 391.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| stomach | 65% | 63.83 | 234 / 359 | 6% | 0.12 | 16 / 286 |
| intestine | 61% | 37.06 | 586 / 966 | 9% | 0.29 | 46 / 527 |
| adrenal gland | 60% | 29.91 | 156 / 258 | 4% | 0.13 | 9 / 230 |
| thymus | 25% | 10.38 | 163 / 653 | 29% | 0.48 | 177 / 605 |
| bladder | 48% | 31.33 | 10 / 21 | 3% | 0.14 | 17 / 504 |
| skin | 23% | 8.73 | 415 / 1809 | 19% | 0.76 | 91 / 472 |
| breast | 31% | 16.40 | 140 / 459 | 8% | 0.20 | 92 / 1118 |
| muscle | 33% | 23.88 | 264 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 33% | 1.90 | 26 / 80 |
| blood vessel | 31% | 40.55 | 414 / 1335 | 0% | 0 | 0 / 0 |
| lung | 19% | 7.36 | 110 / 578 | 9% | 0.31 | 106 / 1155 |
| liver | 16% | 8.24 | 37 / 226 | 5% | 0.18 | 19 / 406 |
| uterus | 11% | 10.22 | 19 / 170 | 6% | 0.35 | 29 / 459 |
| peripheral blood | 16% | 17.73 | 147 / 929 | 0% | 0 | 0 / 0 |
| kidney | 9% | 5.63 | 8 / 89 | 4% | 0.34 | 38 / 901 |
| pancreas | 3% | 1.87 | 11 / 328 | 5% | 0.20 | 9 / 178 |
| esophagus | 3% | 1.09 | 42 / 1445 | 4% | 0.10 | 7 / 183 |
| ovary | 2% | 1.28 | 4 / 180 | 1% | 0.01 | 4 / 430 |
| adipose | 2% | 0.95 | 27 / 1204 | 0% | 0 | 0 / 0 |
| heart | 2% | 1.11 | 16 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0018243 | Biological process | protein O-linked glycosylation via threonine |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | GALNTL6 |
| Protein name | Polypeptide N-acetylgalactosaminyltransferase like 6 GALNTL6 protein Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17) |
| Synonyms | GALNT17 |
| Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. . |
| Accessions | ENST00000511251.1 Q49A17 ENST00000508122.5 [Q49A17-2] ENST00000506823.6 [Q49A17-1] D6RCP4 I6L9C1 |